Why the study?
Is LOX-1 mRNA expression different between epicardial and intramyocardial coronary arteries in patients with advanced coronary artery disease?
Is LOX-1 mRNA expression different between epicardial and intramyocardial coronary arteries in patients with advanced coronary artery disease?
Increased LOX-1 expression in epicardial coronary arteries suggests a potential mechanism for the intramyocardial paradox in atherosclerosis distribution.
LOX-1 expression differences may underlie intramyocardial paradox; hypothesis-generating and requires confirmation before clinical relevance.
Background: Intramyocardial paradox is defined as the difference in atherosclerosis between the intramyocardial and epicardial parts of the coronary arteries in patients with coronary artery disease. The lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) expression has been implicated in the early steps of atherogenesis and may interfere with many factors to induce atherosclerosis. Purpose: These evidences prompted us to investigate the role of LOX-1 as a part of an atherogenetic mechanism by measuring and comparing LOX-1 expression in human epicardial and intramyocardial coronary arteries. Methods: An epicardial and an intramyocardial total artery wall specimen was obtained from 13 male patients, aged 61.9±10.3 years, that underwent coronary artery bypass graft surgery due to advanced three vessel coronary artery disease. All patients underwent total arterial myocardial revascularization using both pedicled mammary arteries and a radial artery, with a mean of 3.6 grafts per patient. A rhomboid shaped total wall ECA and ICA sample, with a long axis of 7–9mm and a short axis of ∼1mm, was obtained by dissection during grafting maneuvers of the vessels from each patient. Reverse transcription-polymerase chain reaction (PT-PCR) was used for LOX-1 mRNA. Total mRNA (1μg) was directly extracted from ECA and ICA samples by the acid guanidium-phenol-chloroform method using RNEasy kit (Qiagen, Germany) according to the manufacturer's protocol. The extracted total RNA was reverse-transcribed using OneStep RT-PCR kit (Qiagen Japan, Tokyo Japan). Reverse –transcribed material (1.5μL) was amplified with DNA polymerase (Invitrogen, California USA) using a primer pair specific to human LOX-1. Each LOX-1 mRNA was normalized with a band of the relative internal reference GAPDH mRNA. The relative intensities of bands of interest were analyzed using Gel Doc 2000 (Bio-Rad Labs, Hercules, CA) and expressed as ratio to the GAPDH mRNA band.
No takes yet. Share an insight, caveat, or question.
Synetos et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: